Unlock this StockReport nowClick to Unlock

Mycelx Technologies Share Price

MYXR 90p 0.0  0.0%
08/05/17 1.50k
StockRank

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ -4.9%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2018, Mycelx Technologies Corp revenues increased 96% to $27M. Net income totaled $3.1M vs. loss of $1.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Loss On Disposal Of Equipment decrease of 79% to $3K (expense), Interest expense decrease of 4% to $85K (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
A+
A+
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2019
31st Dec 2020

Price Target: 2.21
(+63.71% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
1 broker Broker Consensus Trend
Broker Recommendations for Mycelx Technologies
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 0 1 0

Named Brokers and Analysts
Numis Securities , N+1 Singer , Cantor Fitzgerald Europe Adam Forsyth , RFC Ambrian Imogen Whiteside ,

Profile Summary

MYCELX Technologies Corporation (MYCELX) is a clean water technology company. The Company offers solutions for the oil and gas industry's water treatment needs. It provides water treatment solutions to the oil and gas, power, marine and heavy manufacturing sectors. It provides clean water technology equipment and related services. Its MYCELX polymer uses molecular cohesion to remove oil from water to levels the customers require. The core of the MYCELX solution is the MYCELX compound, which consists of a chemical polymer that is infused in the consumable media. The Company sells consumable filtration media on a long-term, recurring basis. It also offers technical services on a recurring basis. It provides water services to manufacturing; power and utilities; facilities and ground water remediation; marine; air filtration, and still response. The MYCELX systems remove oil to low levels in a smaller physical footprint. MYCELX can achieve oil removal to less than one part per million.

Directors: Haluk Alper (PRE) , Connie Mixon (CEO) , Kimberly Slayton (CFO) , Timothy Eggar (NEC) 66, Brian Rochester (NED) , Andre Schnabl (NID) 68,

No. of Employees: 18 No. of Shareholders: n/a


Last Annual December 31st, 2018
Last Interim December 31st, 2018
Incorporated March 24, 1994
Public Since August 4, 2011
Shares in Issue 19,443,750
Free Float 14.3m (73.7%)
Sector Industrials
Industry Professional & Commercial Services
Index
Exchange London Stock Exchange (AIM) (Dual Listing)
Eligible for an ISA? a SIPP?

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy MYXR

Access MYXR Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis